Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Transpl Int. 2018 Apr 22;31(7):761–772. doi: 10.1111/tri.13149

Table 1. Patient Characteristics of DSAPosAMRNeg and DSAPosAMRPos Populations.

Categorical variables were expressed as a percentage and a number, while quantitative variables were expressed either as median with 25–75 interquartile range (IQR) unless specify as § for mean±SD. Fisher or Chi-square tests were used for categorical variables. Mann-Whitney test was used for continuous variables. Abbreviations: AR: acute cellular rejection; BMI: Body Mass Index; CF: Cystic Fibrosis; ECMO: extra corporeal Membrane Oxygenation; EVLP: ex vivo lung preconditioning; GERD: gastro-esophagial reflux; ILD: Interstitial Lung Disease; LAS: Lung Allocation Score; PGD3: Primary Graft Dysfunction grade 3.

Clinical Variable DSAPosAMRNeg (n=23) DSAPosAMRPos (n=15) p value
Recipient Age (years) 38.8 (28.9–50) 33.2 (21.6–56.5) 0.45
Underlying Disease (Emphysema/ILD/CF/others) 7/5/9/2 3/4/6/2 0.88
Gender (F) 16 6 0.1
BMI 19.5 (17.6–22.4) 20.3 (17.9–30) 0.38
LAS 36.40 (32.84–45.40) 35.70 (33.30–41.10) 0.95
Donor Age (years) 49 (40–57) 48 (37–62) 0.71
Donor P/F 372 (307–433) 380 (323–424) 0.67
Ischemia Duration (minutes) 380 (270–442) 379 (340–474) 0.42
HELT 4 (16%) 2 (13%) 1
Peri-op ECMO 9 (40%) 9 (60%) 0.32
EVLP 7 (32%) 1 (6%) 0.11
PGD3 at H72 8 (32%) 1 (6%) 0.06
CMV DR (D−R−/D+R+/D−R+/D+R+) 4/9/4/6 3/5/6/1 0.29
HLA Mismatch § 6.09±1.02 6.93±0.96 0.03
Induction 17 (68%) 10 (66%) 1
AR at M12 § 0.78±0.9 2±1.5 0.01
GERD 16 (84%) 6 (75%) 0.62